Evidence map›Paper›PMID 32448034›Full record

ArticleJournal of biomolecular structure & dynamics2021

Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches.

Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Tyagi, Arvind Bhushan, Madhu Rathore

Open access · greenAbstract read
In one paragraph

Article in Journal of biomolecular structure & dynamics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
23.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 192 citations in OpenAlex.

  1. Article
  2. Drugs against broad-spectrum of coronaviruses.Frontiers in immunology · 2026
    Review
  3. Pharmaceutics · 2025
    Review
  4. Impact of Glucose, Inflammation and Phytochemicals onAntioxidants (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Discovery of Anti-Coronavirus Cinnamoyl Triterpenoids Isolated fromInternational journal of molecular sciences · 2023
    Article
  11. Review
  12. Viruses · 2023
    Article
  13. Article
  14. Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 MPharmaceuticals (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. A Brief Review on Medicinal Plants-At-Arms against COVID-19.Interdisciplinary perspectives on infectious diseases · 2023
    Review
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Anuj KumarBioinformatics Laboratory, Uttarakhand Council for Biotechnology (UCB), Pantnagar, India.ORCID 0000-0002-5023-7618
Gourav ChoudhirDepartment of Botany, CCS University, Meerut, India.
Sanjeev Kumar ShuklaMultidisciplinary Research Unit (MRU), Government Medical College, Haldwani, India.
Mansi SharmaAcademy of Biological Science & Research Foundation (ABSRF), Udaipur, India.ORCID 0000-0002-4026-5498
Pankaj TyagiDepartment of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida, India.
Arvind BhushanIIHMR University, Jaipur, India.
Madhu RathoreAcademy of Biological Science & Research Foundation (ABSRF), Udaipur, India.
Chaudhary Charan Singh University · INGovernment Medical College · INIIHMR University · INJaypee Institute of Information Technology · INUttarakhand State Council for Science and Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel corona virus that causes corona virus disease 2019 (COVID-19). The COVID-19 rapidly spread across the nations with high mortality rate even as very little is known to contain the virus at present. In the current study, we report novel natural metabolites namely, ursolic acid, carvacrol and oleanolic acid as the potential inhibitors against main protease (M

Indexed as

Coronavirus 3C ProteasesMolecular Docking SimulationPhytochemicalsProtease InhibitorsSARS-CoV-23C-like proteinase, SARS-CoV-2Coronavirus 3C ProteasesPhytochemicalsProtease InhibitorscarvacrolCOVID-19oleanolic acidproteaseursolic acid

Identifiers

PMID32448034
PMCPMC7284142
OpenAlexW3027469981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.